Jay R. Luly - Feb 12, 2025 Form SCHEDULE 13D/A Schedule Report for Enanta Pharmaceuticals, Inc. (ENTA)

Filing Manager: Luly Jay R.
Reporting Manager: Jay R. Luly, Ph.D.
Security: Enanta Pharmaceuticals, Inc. Common Stock, par value $0.01 per share
Symbol: ENTA
Shares outstanding: 22.1M shares
Disclosed Ownership: 1.7M shares
Ownership: 7.7%
Form type: SCHEDULE 13D/A
Date filed: 2/14/2025, 05:05 PM
Date of event: Feb 12, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Jay R. Luly, Ph.D.	7.7%	1.7M	1.7M	0	/s/ Jay R. Luly, Ph.D.	Jay R. Luly, Ph.D.	0001571211